Cresco Labs (CRLBF) Non Operating Income (2020 - 2026)
Cresco Labs (CRLBF) reported Non Operating Income of -$14.0 million for Q1 2026, up 3.72% on a YoY basis from -$13.5 million in Q1 2025, and down 20.41% quarter-over-quarter from -$11.6 million in Q4 2025.
Cresco Labs (CRLBF) Non Operating Income (2020 - 2026) Analysis & Trends
Cresco Labs has reported Non Operating Income for 7 years, with the latest figure at -$14.0 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income rose 3.72% year-over-year to -$14.0 million; the trailing twelve-month figure through Mar 2026 stood at -$66.9 million (up 43.88% YoY), and the FY2025 full-year result was -$11.2 million, up 90.54% from the prior year.
- Non Operating Income for Q1 2026 stood at -$14.0 million, down from -$11.6 million in the prior quarter.
- The five-year high for Non Operating Income was -$757000.0 in Q3 2022, with the low at -$73.3 million in Q2 2024.
- Historically, Non Operating Income has averaged -$17.7 million across 5 years, with a median of -$14.3 million in 2023.
- Annual changes were most pronounced in 2022 — Non Operating Income soared 93.61% — and 2023, when it tumbled 1410.57%.
- Cresco Labs' Non Operating Income stood at -$13.4 million in 2022, then dropped by 6.71% to -$14.3 million in 2023, then slipped by 14.49% to -$16.4 million in 2024, then rose by 29.06% to -$11.6 million in 2025, then fell by 20.41% to -$14.0 million in 2026.
- The last three Non Operating Income figures came in at -$14.0 million (Q1 2026), -$11.6 million (Q4 2025), and -$27.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 53.40 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | -34,272.67 |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 5.71 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | -4.72 Mn |
| 10 | Cresco Labs | - | - | 75.45 Mn | -13.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.97 Mn |
| Dec 31, 2025 | -11.60 Mn |
| Sep 30, 2025 | -27.93 Mn |
| Jun 30, 2025 | -13.40 Mn |
| Mar 31, 2025 | -14.51 Mn |
| Dec 31, 2024 | -16.35 Mn |
| Sep 30, 2024 | -15.02 Mn |
| Jun 30, 2024 | -73.32 Mn |
| Mar 31, 2024 | -13.22 Mn |
| Dec 31, 2023 | -14.28 Mn |
| Sep 30, 2023 | -11.44 Mn |
| Jun 30, 2023 | -18.77 Mn |
| Mar 31, 2023 | -14.59 Mn |
| Dec 31, 2022 | -13.38 Mn |
| Sep 30, 2022 | -757,000.00 |
| Jun 30, 2022 | -7.34 Mn |
| Mar 31, 2022 | -21.14 Mn |
| Dec 31, 2021 | -3.94 Mn |
| Sep 30, 2021 | -11.84 Mn |
| Jun 30, 2021 | 1.24 Mn |